Bellerophon Therapeutics, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Bellerophon Therapeutics, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:LiabilitiesFairValueDisclosure · last filed 2023-11-14
- 2023-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2023-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2023-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2022-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-14 |